Does Rallies show 13F holders for CDTX?

Yes. Rallies tracks hedge fund and 13F ownership data for CDTX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is CDTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CDTX. It does not provide personalized investment advice.

CDTX (Cidara Therapeutics, Inc.) Stock Analysis - Hedge Fund Holdings

Cidara Therapeutics, Inc. (CDTX) is a publicly traded Healthcare sector company. As of May 20, 2026, CDTX trades at $221.38 with a market cap of $6.96B and a P/E ratio of -8.28. CDTX moved +0.03% today. Year to date, CDTX is +228.02%; over the trailing twelve months it is +731.63%. Its 52-week range spans $10.14 to $221.42. Analyst consensus is buy with an average price target of $221.50. Rallies surfaces CDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CDTX stock?

Hedge funds tracked by Rallies that own CDTX include Pentwater Capital, Maverick Capital, Farallon Capital, Soros Fund, and Davidson Kempner. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cidara Therapeutics, Inc..

CDTX Key Metrics

Key financial metrics for CDTX
Metric	Value
Price	$221.38
Market Cap	$6.96B
P/E Ratio	-8.28
EPS	$-26.75
Dividend Yield	0.00%
52-Week High	$221.42
52-Week Low	$10.14
Volume	2.69M
Avg Volume	0
Revenue (TTM)	$1.27M
Net Income	$-169.83M
Gross Margin	0.00%

Top Hedge Funds Holding CDTX

Pentwater Capital holds 565.00K shares of CDTX, changed +0.00% as of Dec 31, 2025.
Maverick Capital holds 455.98K shares of CDTX, changed +9.20% as of Dec 31, 2025.
Farallon Capital holds 382.80K shares of CDTX, changed -62.32% as of Dec 31, 2025.
Soros Fund holds 275.00K shares of CDTX, changed +0.00% as of Dec 31, 2025.
Davidson Kempner holds 155.63K shares of CDTX, changed +0.00% as of Dec 31, 2025.

Recent CDTX Insider Trades

Ward Shane sold 9.96K (~$2.19M) on Dec 10, 2025.
Davarpanah Nicole Negar sold 474 (~$29.80K) on Sep 11, 2025.
RA CAPITAL MANAGEMENT, L.P. bought 2.27M (~$100.00M) on Jun 26, 2025.

CDTX Analyst Consensus

11 analysts cover CDTX: 1 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $221.50.

Common questions about CDTX

Who owns CDTX stock?: Hedge funds tracked by Rallies that own CDTX include Pentwater Capital, Maverick Capital, Farallon Capital, Soros Fund, and Davidson Kempner. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cidara Therapeutics, Inc..
Does Rallies show 13F holders for CDTX?: Yes. Rallies tracks hedge fund and 13F ownership data for CDTX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CDTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CDTX. It does not provide personalized investment advice.